http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113462780-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate | 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113462780-B |
titleOfInvention | Marker and kit for auxiliary diagnosis of prostate cancer |
abstract | The invention belongs to the technical field of medical biology, and discloses a molecular marker LncRNA SNHG11 for auxiliary diagnosis of prostate cancer. LncRNA SNHG11 is highly expressed in cancerous tissues of prostate cancer and is poorly expressed in paracancerous normal tissues; moreover, the expression level of LncRNA SNHG11 in prostate cancer cell lines was significantly higher than that of normal prostate cell lines; by knocking down the expression level of LncRNA SNHG11 gene, the proliferation, migration and invasion of prostate cancer cells can be obviously inhibited. Therefore, the LncRNA SNHG11 can be used as a molecular marker for the auxiliary diagnosis of the prostate cancer; by detecting the expression level of LncRNA SNHG11 in a sample, the auxiliary diagnosis of the prostate cancer can be carried out, and a reference basis is provided for a clinician to diagnose the prostate cancer. |
priorityDate | 2021-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 217.